OK, these finds are *actually* worth checking out. View Entire Post › ...

Arexvy, GSK's RSV vaccine, is now approved for all adults 18+ in the EU, addressing a significant public health concern. RSV ...

China NMPA approves GSK’s Trelegy Ellipta for use in adults with uncontrolled asthma: London, UK Saturday, January 24, 2026, 09:00 Hrs [IST] GSK plc announced that China’s Nat ...

Asthma inhalers are critical for delivering small amounts of medication to people's lungs to improve breathing and help prevent asthma attacks, but those tiny puffs add up to a large environmental ...

(NEXSTAR) – That small whoosh from an inhaler has a substantial environmental toll that could be putting some people with chronic conditions at risk, according to a new study. Published Monday in the ...

Cambridge Healthcare Innovations (CHI) announced the availability of its dry powder inhaler (DPI) engine for clinical trials later this year. The startup developed Quattrii to deliver large volumes of ...

The increase in respiratory diseases worldwide, coupled with the potential for systematic drug delivery, has led to a shifting landscape within inhaled drug delivery. As an alternative to pressurised ...

GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, Arizona lawsuit says.

The incidence of a first moderate or severe chronic obstructive pulmonary disease exacerbation was higher in patients who received budesonide-glycopyrrolate-formoterol compared with those who received ...

1. In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was not associated with improved clinical outcomes compared to receiving ...